A detailed history of M. Kulyk & Associates, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 21,313 shares of BDX stock, worth $4.86 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
21,313
Previous 20,843 2.25%
Holding current value
$4.86 Million
Previous $4.87 Million 5.48%
% of portfolio
1.05%
Previous 1.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$221.47 - $242.41 $104,090 - $113,932
470 Added 2.25%
21,313 $5.14 Million
Q2 2024

Aug 05, 2024

BUY
$225.07 - $246.17 $314,422 - $343,899
1,397 Added 7.18%
20,843 $4.87 Million
Q1 2024

May 09, 2024

BUY
$233.45 - $247.73 $519,893 - $551,694
2,227 Added 12.93%
19,446 $4.81 Million
Q4 2023

Feb 08, 2024

BUY
$232.24 - $267.23 $134,466 - $154,726
579 Added 3.48%
17,219 $4.2 Million
Q3 2023

Nov 07, 2023

BUY
$254.9 - $283.59 $206,214 - $229,424
809 Added 5.11%
16,640 $4.3 Million
Q2 2023

Aug 08, 2023

BUY
$238.39 - $265.32 $104,176 - $115,944
437 Added 2.84%
15,831 $4.18 Million
Q1 2023

May 08, 2023

BUY
$229.71 - $259.35 $126,799 - $143,161
552 Added 3.72%
15,394 $3.81 Million
Q4 2022

Feb 08, 2023

BUY
$218.29 - $256.91 $92,991 - $109,443
426 Added 2.96%
14,842 $3.78 Million
Q3 2022

Nov 07, 2022

BUY
$51.03 - $264.23 $56,030 - $290,124
1,098 Added 8.24%
14,416 $3.21 Million
Q2 2022

Aug 05, 2022

BUY
$234.74 - $275.42 $288,730 - $338,766
1,230 Added 10.18%
13,318 $3.28 Million
Q1 2022

May 11, 2022

BUY
$243.64 - $270.48 $2.63 Million - $2.92 Million
10,811 Added 846.59%
12,088 $3.22 Million
Q4 2021

Jan 20, 2022

BUY
$230.08 - $250.94 $293,812 - $320,450
1,277 New
1,277 $321,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track M. Kulyk & Associates, LLC Portfolio

Follow M. Kulyk & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M. Kulyk & Associates, LLC with notifications on news.